![Endometrial cancer prognosis in women with endometriosis and adenomyosis: A retrospective nationwide cohort study of 40 840 women - Hermens - 2022 - International Journal of Cancer - Wiley Online Library Endometrial cancer prognosis in women with endometriosis and adenomyosis: A retrospective nationwide cohort study of 40 840 women - Hermens - 2022 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f4a630b6-11bd-4fd6-ae8e-0cae8dc6ef7f/ijc33907-toc-0001-m.png)
Endometrial cancer prognosis in women with endometriosis and adenomyosis: A retrospective nationwide cohort study of 40 840 women - Hermens - 2022 - International Journal of Cancer - Wiley Online Library
![a Endometrial cancer-related survival by 4 molecular subgroups in the... | Download Scientific Diagram a Endometrial cancer-related survival by 4 molecular subgroups in the... | Download Scientific Diagram](https://www.researchgate.net/publication/334810742/figure/fig2/AS:962682559676434@1606532816529/a-Endometrial-cancer-related-survival-by-4-molecular-subgroups-in-the-PORTEC-2-trial-for.png)
a Endometrial cancer-related survival by 4 molecular subgroups in the... | Download Scientific Diagram
![Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification - ScienceDirect Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825822001433-ga1.jpg)
Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification - ScienceDirect
![Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis - Gynecologic Oncology Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis - Gynecologic Oncology](https://www.gynecologiconcology-online.net/cms/asset/df1047a1-371b-4e49-9cda-931798aa350b/gr1.jpg)
Impact of treatment modality on overall survival in women with advanced endometrial cancer: A National Cancer Database analysis - Gynecologic Oncology
![NEJM on X: "In women with advanced endometrial cancer, the median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months NEJM on X: "In women with advanced endometrial cancer, the median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months](https://pbs.twimg.com/media/FJf6WueVIAMWHvU.jpg)
NEJM on X: "In women with advanced endometrial cancer, the median progression-free survival was 7.2 months with lenvatinib plus pembrolizumab and 3.8 months with chemotherapy; the median overall survival was 18.3 months
![Cancers | Free Full-Text | Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy? Cancers | Free Full-Text | Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?](https://pub.mdpi-res.com/cancers/cancers-14-00912/article_deploy/html/images/cancers-14-00912-g001.png?1645068354)
Cancers | Free Full-Text | Prognosis Stratification Tools in Early-Stage Endometrial Cancer: Could We Improve Their Accuracy?
![Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer: Molecular Therapy - Nucleic Acids Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/a1df7c8a-cd7c-45c7-8020-ff4fcfff0f05/gr1.jpg)
Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer: Molecular Therapy - Nucleic Acids
![Kaplan-Meier survival curves for overall survival (A) and failure-free... | Download Scientific Diagram Kaplan-Meier survival curves for overall survival (A) and failure-free... | Download Scientific Diagram](https://www.researchgate.net/publication/334619415/figure/fig3/AS:789913532370945@1565341470305/Kaplan-Meier-survival-curves-for-overall-survival-A-and-failure-free-survival-B-among.png)
Kaplan-Meier survival curves for overall survival (A) and failure-free... | Download Scientific Diagram
![Frontiers | Endometrial Cancer Type 2 Incidence and Survival Disparities Within Subsets of the US Black Population Frontiers | Endometrial Cancer Type 2 Incidence and Survival Disparities Within Subsets of the US Black Population](https://www.frontiersin.org/files/Articles/699577/fonc-11-699577-HTML/image_m/fonc-11-699577-g001.jpg)
Frontiers | Endometrial Cancer Type 2 Incidence and Survival Disparities Within Subsets of the US Black Population
![Patterns of failure after adjuvant “sandwich” chemo-radio-chemotherapy in locally advanced (stage III–IVA) endometrial cancer | SpringerLink Patterns of failure after adjuvant “sandwich” chemo-radio-chemotherapy in locally advanced (stage III–IVA) endometrial cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00432-020-03339-y/MediaObjects/432_2020_3339_Fig1_HTML.png)
Patterns of failure after adjuvant “sandwich” chemo-radio-chemotherapy in locally advanced (stage III–IVA) endometrial cancer | SpringerLink
![434 Cytoreductive surgery in stage IV endometrial cancer: A retrospective multicentre cohort study | International Journal of Gynecologic Cancer 434 Cytoreductive surgery in stage IV endometrial cancer: A retrospective multicentre cohort study | International Journal of Gynecologic Cancer](https://ijgc.bmj.com/content/ijgc/31/Suppl_3/A94.3/F1.large.jpg)
434 Cytoreductive surgery in stage IV endometrial cancer: A retrospective multicentre cohort study | International Journal of Gynecologic Cancer
![Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion | International Journal of Gynecologic Cancer Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion | International Journal of Gynecologic Cancer](https://ijgc.bmj.com/content/ijgc/32/9/1129/F2.large.jpg)
Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion | International Journal of Gynecologic Cancer
![Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival | British Journal of Cancer Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2015.200/MediaObjects/41416_2015_Article_BFbjc2015200_Fig1_HTML.jpg)
Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival | British Journal of Cancer
![Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis | BMC Cancer | Full Text Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-022-09510-7/MediaObjects/12885_2022_9510_Fig3_HTML.png)
Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis | BMC Cancer | Full Text
![A clinically applicable molecular-based classification for endometrial cancers | British Journal of Cancer A clinically applicable molecular-based classification for endometrial cancers | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2015.190/MediaObjects/41416_2015_Article_BFbjc2015190_Fig1_HTML.jpg)
A clinically applicable molecular-based classification for endometrial cancers | British Journal of Cancer
![Prognostic Factors for Endometrial and Cervical Cancers of Uterus Treated With Immune-cell Therapy: A Retrospective Study | Anticancer Research Prognostic Factors for Endometrial and Cervical Cancers of Uterus Treated With Immune-cell Therapy: A Retrospective Study | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/8/4729/F2.large.jpg)